Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expressionChanglin Li(Liaoning University of Traditional Chinese Medicine), Benyi Li(University of Kansas Medical Center)Cellular OncologyJuly 24, 202010.1007/s13402-020-00544-2Cited by 63SaveCiteExport RISWatch citationsRelated PapersA circuit from lateral septum neurotensin neurons to tuberal nucleus controls hedonic feeding|Molecular Psychiatry|2022|62Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells|BMC Cancer|2021|9Transcriptome and Proteome Analysis Reveals Corosolic Acid Inhibiting Bladder Cancer via Targeting Cell Cycle and Inducing Mitophagy in Vitro and in Vivo|Research Square|2021|3